Last reviewed · How we verify

NCT04410016: COVID-WELL

Evaluation of Staff COVID-19 Wellbeing Centres in a Healthcare Workplace: COVID-WELL Study

Completed NA Last updated 30 August 2021
What this trial tests

NA trial testing Staff Wellbeing Centres in Mental Health Wellness 1 in 819 participants. Completed in 30 October 2020.

Timeline
25 May 2020
Primary endpoint
31 July 2020
30 October 2020

Quick facts

Lead sponsorUniversity of Nottingham
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment819
Start date25 May 2020
Primary completion31 July 2020
Estimated completion30 October 2020
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

University of Nottingham

Who can join

Eligibility, any sex, with Mental Health Wellness 1. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluation of a workplace intervention to implement supported wellbeing centres in a healthcare workplace during and after the COVID-19 pandemic. Mixed-Methods Evaluation study - including collection of service use monitoring data, online survey and qualitative interviews.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Mental Health Wellness 1

Currently open trials in the same condition.

Other University of Nottingham trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04410016.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing